• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The invention relates to novel pyrazolo[1,5-c]quinazoline derivatives of the general formula I <IMAGE> (XIX) wherein R represents a hydrogen atom, a C1-4 alkyl group or an acyl group, R1 represents a hydrogen atom, a C1-12 alkyl group, a C3-8 cycloalkyl group, a C2-4 alkenyl group, an aralkyl group, wherein the alkyl group has 1 to 4 carbon atoms, a phenylalkenyl group, wherein the alkenyl group has 2 to 4 carbon atoms, furthermore a carboxy group or a phenyl group optionally substituted by one or more substituents selected from the group consisting of halogen, hydroxy, C1-4 alkoxy, nitro or di(C1-4 alkyl)amino groups, or R and R1 may form together a valence bond, R2 represents a hydrogen atom, a C1-4 alkyl or a phenyl group, or R1 and R2 may form together a C2-7 alkylene group, R3 represents a nitro group, an amino group, an alkylamino group, a dialkylamino group, wherein the alkyl groups have 1 to 4 carbon atoms, an alkylideneimino group, wherein the alkylidene group has 1 to 4 carbon atoms, a benzylideneimino group or an acylamino group, and pharmaceutically acceptable acid addition salts thereof. The novel compounds of the general formula I can be employed primarily as analgesic agents.
    公开号:SU1015828A3
    申请号:SU813287448
    申请日:1981-05-26
    公开日:1983-04-30
    发明作者:Береньи Эдит；Сирт Енике；Герег Петер；Петец Луиза；Кошоцки Иболиа；Ковач Агнеш；Юрмеш Габриелла
    申请人:Эдьт Дьедьсерведьесети Дьяр (Инопредприятие)；
    IPC主号:
    专利说明:

    : d eo
    ND X The invention relates to a process for the preparation of new pyrazo (1,5-C) quinazoline derivatives of the general formula (I where R, j is hydrogen; 2. alkanoyl; Or their salts with analgesic properties. The reaction of amine acylation is known, in particular reacting amines with aliphatic carboxylic acids or with their anhydrides by heating C-J The purpose of the invention is to synthesize new compounds with valuable pharmaceutical properties. The goal is that the compound is the general formula (I) where R., R2 is hydrogen, acylirhawth aliphatic carboxylic acid with carbon 1 atom or its anhydride by isolating the desired product in free form or as a salt. Pharmaceutically suitable salts with acids of compounds of the general formula (I.) can be formed with inorganic acids, such as hydrochloric, sulfuric and phosphoric, as well as with organic acids, for example, fumaric, acetic, maleic and citric. Example (preparation of starting materials). 1-Nitropyrazolo (1,5-C) quinazoline. A. 5- (P-Aminophenyl) -4-nitropyrazole. 20.8 g (0.1 mol) of 4-chloro-3-nitro-quinoline are refluxed for 2 hours with 40 ml of benzene and 40 ml of hydrazine hydrate. After cooling, the mixture of the phase is separated. The phase containing hydrazine. hydrate, diluted with 150 ml of water. 16.8 g (83% of theoretical) product as yellow-white crystals falls out. M.p. 175-176s (from this nola). B. 1-Nitropyrazolo (1,5-C) quinazolin. A mixture of 20.4 g (0.1 mol) of 5- (o-aminophenyl) -4-nitropyrazole, 250 ml of ethyl orthoformate and 0.1 g of p-toluenesulfonic acid is heated at 120–13 ° C for 2 hours and the ethanol formed in this reaction is continuously tipped off. From the obtained dark brown solution, 1-nitropyrazolo (1,5-С) quinazoline falls out during cooling. Get 19,7 g (92% of theoretical;) product. M.p. 177-178 ° C. PRI mme R 2. 1-Aminopyrazolo (1,5-C) quinazoline. 21.4 g (0.1 mol) of 1-nitropyrazolo (1,5-C) quinazoline is hydrogenated in ethanol in the presence of a palladium catalyst at room temperature and atmospheric pressure. At the end of the hydrogen uptake, the suspension is filtered and evaporated. 14.7 g (80% of theory) of 1-aminopyrazolo (1,5-C) quinazoline are obtained. M.p. 168170С. PRI me R 3. 1-Acetaminopyrazolo (1,5-C) quinazoline. 19.8 g (0.1 mol) of 1-aminopyrazolo. (1,5-C) quinazoline is boiled for 1 hour in 100 ml of acetic anhydride. The product precipitated after cooling is filtered, washed and dried. Get 22,0 g (90% of theoretical) 1-acetaminopyrazolo (1,5-C) quinazoline. M.p. 256-258 p. PRI me R 4. (getting the source). 1-Propianamino pyrazolo (1,5-C) quinazolin. 1-Aminopyrazolo (1,5-C) quinazoline is reacted with propionic anhydride in analogy to Example 3. 1-Propionylaminopyrazolo (1,5-C) quinazoline is obtained. M.p. 202-204С. The compounds of general formula (I) are biologically active in numerous pharmacological tests. The analgesic action, the action aimed at reducing the acidity of gastric secretion, and the anti-peristaltic action were especially manifested. The toxicity of the compounds according to Example 3 was determined in mice by oral administration (mg / kg). The effect of the proposed compounds on the acidity level of gastric secretion was studied in hungry rats of both sexes weighing 170-260 g according to the Shay method (Gastroenterology, 5.43, (1945)). The decrease in the acidity level in the gastric juice is given in table. one.
    Table
    Offer (for example 3)
    Atropine
    (200 mg / kg) eo
    Proglumid
    (2774 mg / kg)
    Cimetidine
    (LD 470 mg / kg). The anti-peristaltic effect of new compounds of the general formula () was investigated in mice. The test compounds were orally administered in various doses and an hour later thereafter a 10% coal suspension was injected. After another 20 minutes, the animals were sacrificed and the length of the entire small intestine and the length of the section of the thin hemlock filled with coal were measured. Each dose was tested on 10 mice. As a comparative compound, papaverine - 1- (3 4-dimethyxibenzyl) -6,7-dimethoxy-isoquinoline was used. The results are shown in. Table. 2
    50 93 45 15-24
    28,57
    4 11.38
    45
    9.4 their change as kih T and e.jiLLL. The compounds of the general formula (I) and olives with acids can be used in therapy mainly for the active principles of analgesic drugs.
    权利要求:
    Claims (1)
    [1]
    A method of obtaining derivatives of pyrazolo (1,5-C) quinazoline of the general formula p.
    where R t is hydrogen;
    R1 is alkanoyl, or their salts, characterized in that the compound of general formula (I), where R ^ is hydrogen, is acylated with an aliphatic carboxylic acid with 1-4 carbon atoms or its anhydride with the isolation of the desired product ( product in free form) or in the form of salt.
    类似技术:
    公开号 | 公开日 | 专利标题
    FI87766B|1992-11-13|FORM OF THERAPEUTIC ACTIVATION OF THERAPEUTIC ACTIVE N- | BENZENE DERIVATIVES
    SU1681728A3|1991-09-30|Method for preparation of n-|amide derivatives of benzoic or thiazol-4-carboxylic acid
    SU978730A3|1982-11-30|Process for producing ethyl ester of 9-phenylhydrazone-6-methyl-4-oxo-6,7,8,8-tetrahydro-4h-pirido-[1,2-a]-pyrimidine-3-carboxylic acid
    GB2037766A|1980-07-16|1,4-dihydropyridines, their preparation and pharmaceutical compositions containing them
    US3962258A|1976-06-08|1,2,3,4,6,7,12,12B-Octahydro-2-benzamidoindolo[2,3-a]quinolizine
    SU1015828A3|1983-04-30|Process for preparing derivatives of pyrazolo | quinazoline or their salts
    US3567765A|1971-03-02|N-aromatic substituted acid amides and esters
    US4034093A|1977-07-05|4|-pyrimidinones
    US4320061A|1982-03-16|2,3,4,5-Tetrahydro-1-benzoxepin-3,5-dione derivatives
    SU1591813A3|1990-09-07|Method of producing enol esters of amides of 1,1-dioxo-3-chloro-4-oxy-2-methyl-n-|-2n-thieno|thiazine-3-carbolic acid
    US4578460A|1986-03-25|N-6-aminopurinyl-4-hydroxy-2-methyl-2H-1,2-benxothiazine-3-carboxamide 1,1-dioxide compound
    US5057526A|1991-10-15|Pharmaceutically active pyridinyl substituted 5,7-dihydropyrrolo-[3,2-f]benzoxazole-6-ones
    HU185193B|1984-12-28|Process for preparing new, basically substituted 4-phenyl-4,5,6,7-tetrahydro-thieno/2,3-c/pyridines
    US4757070A|1988-07-12|3-oxadiazolyl-5-aminoalkyl-beta-carboline derivatives compositions and use
    US4452789A|1984-06-05|1-Furyl-3,4-dihydro-isoquinolines
    US4025550A|1977-05-24|Derivatives of triiodo-aminobenzenecarboxylic acids and the preparation thereof
    US3998823A|1976-12-21|Novel derivatives of maleopimaric acid
    FI68622C|1985-10-10|FOERFARANDE FOER FRAMSTAELLNING AV INDOLAETTIKSYRADERIVAT
    CA1110249A|1981-10-06|Indolopyrones having antiallergic activity
    US4500708A|1985-02-19|Benzothiazine derivatives
    RU2068415C1|1996-10-27|5,7-dihydroxy-2-methyl-8-[4-|-|piperidinyl]-4h-1-benzopyran-4-one or its stereoisomers or pharmacologically acceptable acid-additive salts and a method of their synthesis
    KR800001630B1|1980-12-31|Process for the preparation of benzylamines
    Al‐Talib et al.1988|A convenient synthesis of amino‐substituted 1, 3, 5‐oxadiazinium salts
    US4477451A|1984-10-16|5,6-Dihydro-11-methylenemorphanthridin-6-ones, their preparation and drugs containing these compounds
    SU1456016A3|1989-01-30|Method of producing imidazole-containing compounds or acid-additive salts thereof
    同族专利:
    公开号 | 公开日
    DD150897A5|1981-09-23|
    GR68462B|1981-12-30|
    CS340780A2|1985-06-13|
    HU178523B|1982-05-28|
    DE3019019A1|1980-11-27|
    ES491608A0|1981-05-16|
    CS241026B2|1986-03-13|
    FR2456744B1|1983-06-17|
    DE3019019C2|1988-12-01|
    JPS55154974A|1980-12-02|
    ATA262580A|1984-02-15|
    JPH0227356B2|1990-06-15|
    ES8105319A1|1981-05-16|
    FR2456744A1|1980-12-12|
    IT8022111D0|1980-05-16|
    GB2051054A|1981-01-14|
    AU5848580A|1980-11-20|
    NL8002853A|1980-11-20|
    GB2051054B|1983-05-18|
    CH646170A5|1984-11-15|
    US4303660A|1981-12-01|
    SU1017171A3|1983-05-07|
    SU978731A3|1982-11-30|
    BE883204A|1980-11-10|
    IT1149882B|1986-12-10|
    AT375941B|1984-09-25|
    AU528013B2|1983-03-31|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US3313815A|1964-05-04|1967-04-11|Sterling Drug Inc|8-chloropyrazolo-[1, 5-c]quinazoline derivatives and methods of preparing same|
    US3531482A|1966-10-13|1970-09-29|Sandoz Ag|Pyrazoloquinazolines|
    US3897434A|1974-04-12|1975-07-29|Lilly Co Eli|Pyrazolo{8 1,5-c{9 quinazolin-5-ones|
    US4076818A|1976-07-02|1978-02-28|E. R. Squibb & Sons, Inc.|Pyrazolo [1,5-C]quinazoline derivatives and related compounds|
    US4110452A|1977-10-17|1978-08-29|E. R. Squibb & Sons, Inc.|Pyrazolo quinazoline derivatives and related compounds|
    US4112098A|1977-10-17|1978-09-05|E. R. Squibb & Sons, Inc.|Pyrazolo[1,5-c]quinazoline derivatives and related compounds|
    US4198412A|1978-12-13|1980-04-15|E. R. Squibb & Sons, Inc.|Pyrazolo [1,5-C] quinazoline derivatives and their use in treating allergic conditions|US4469868A|1982-05-24|1984-09-04|Warner-Lambert Company|Alkylimidazo[1,2-c]pyrazolo[3,4-e]pyrimidines|
    DE3942357A1|1989-12-21|1991-06-27|Boehringer Mannheim Gmbh|3-AMINOPYRAZOLO-HETEROCYCLES, THEIR USES FOR THE DETERMINATION OF HYDROGEN PEROXIDE, HYDROGEN PEROXIDE-FORMING SYSTEMS, PEROXIDASE, PEROXIDATIALLY ACTIVE SUBSTANCES OR OF ELECTRONIC AROMATIC COMPOUNDS, CORRESPONDING PROCEDURES AND COMPOUNDS THEREOF|
    JP2002537397A|1999-02-22|2002-11-05|ベーリンガーインゲルハイムファーマシューティカルズインコーポレイテッド|Polycyclic heterocyclic derivatives as anti-inflammatory agents|
    GB2454549B|2007-09-25|2009-09-23|Medical & Pharm Ind Tech & Dev|Uses of 2-[piperidinyl]methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5-one for providing an anti-allergic effect and histamine H1 receptor antagonism effect|
    CN103130810B|2013-03-11|2015-02-25|河南师范大学|Synthesis method of pyrrolo[1,5-c] quinazoline compounds|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    HU79EE2663A|HU178523B|1979-05-18|1979-05-18|Process for preparing new pyrazolo-quinazoline derivatives|
    [返回顶部]